Clinical Trial Update: Phase 2a MIB-626 vs. Placebo COVID-19 [Phase 2]

View source ↗

Summary

A Phase 2a trial of MIB-626 vs placebo in COVID-19 patients with Stage 1 Acute Kidney Injury has completed the Phase 2 study. No efficacy results are provided i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• MIB-626

Snippet

Sponsor: Metro International Biotech, LLC | Conditions: Covid19, Stage 1 Acute Kidney Injury | Phase 2 | Status: COMPLETED